Dr. Anthony Reder Managed a Clinical Trial Site for Ocrelizumab, Newly Approved Breakthrough Multiple Sclerosis Drug

Article ID: 672046

Released: 29-Mar-2017 11:05 AM EDT

Source Newsroom: University of Chicago Medical Center

Expert Pitch
  • newswise-fullscreen Dr. Anthony Reder Managed a Clinical Trial Site for Ocrelizumab, Newly Approved Breakthrough Multiple Sclerosis Drug

    Anthony Reder, MD

Dr. Anthony Reder is an expert on multiple sclerosis (MS) and an instrumental faculty member in the University of Chicago Medicine's large MS program. He managed a clinical trial site for Ocrevus (ocrelizumab), a breakthrough treatment for MS recently approved by the FDA.

  • share-facebook-Dr. Anthony Reder Managed a Clinical Trial Site for Ocrelizumab, Newly Approved Breakthrough Multiple Sclerosis Drug
  • share-twitter-Dr. Anthony Reder Managed a Clinical Trial Site for Ocrelizumab, Newly Approved Breakthrough Multiple Sclerosis Drug

Comment/Share

step 2
Chat now!